Patent holdings for IPC class C07C 215/42

Total number of patents in this class: 71

10-year publication summary

6
6
6
8
6
1
2
4
0
0
2016 2017 2018 2019 2020 2021 2022 2023 2024 2025

Principal owners for this class

Owner
All patents
This class
Bristol-myers Squibb Company
4848
9
Techfields Biochem Co. Ltd
17
6
Atrogi AB
52
4
Sunovion Pharmaceuticals Inc.
271
4
Advancion Corporation
110
4
Grünenthal GmbH
583
3
Taro Pharmaceuticals Inc.
37
3
Bayer Pharma AG
1058
2
Aquinox Pharmaceuticals (Canada) Inc.
10
2
OCERA Therapeutics, Inc.
40
2
Shandong Luye Pharmaceutical Co., Ltd.
63
2
Recurium IP Holdings, LLC
131
2
UNM Rainforest Innovations
404
2
Neusignal Therapeutics, Inc.
4
2
F. Hoffmann-La Roche AG
7889
1
BASF SE
20616
1
Janssen Pharmaceutica N.V.
3436
1
Toshiba Corporation
12246
1
Bayer AG
3254
1
Dow Global Technologies LLC
10247
1
Other owners 18